• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » SRI International completes R&D facility expansion

SRI International completes R&D facility expansion

October 25, 2013
CenterWatch Staff

SRI International has completed the final stage of expansion of its 40,000-square-foot R&D facility in Harrisonburg, Va. SRI funded the $2.8 million build-out to further advance its bioscience research capabilities at SRI's Shenandoah Valley (SRI SV) Center for Advanced Drug Research.

SRI's new biomedical facilities include more than 2,500 square feet of laboratory and storage areas for preclinical research, drug discovery and drug development programs. R&D at SRI Shenandoah Valley focuses on basic research, including emerging infectious diseases, metabolic diseases and proteomics; therapeutic discovery and development of drugs, vaccines and biologics; and personalized medicine, such as companion diagnostics and biomarkers.

As part of SRI's growth, SRI Biosciences has expanded its team. New hires include Thomas Voss, Tianyi "Tony" Wang and Lynn Chellarajan.

Voss, Ph.D., director of virology, Center for Immunology and Infectious Diseases, is researching new models for developing treatments for influenza and other infectious diseases. He joined SRI from the faculty of Tulane School of Medicine's department of microbiology and immunology. Previously, he worked in at Southern Research Institute, ultimately as vice president of the Homeland Security and Emerging Infectious Disease Division.

Wang, Ph.D., senior scientist, virology, Center for Immunology and Infectious Diseases, studies the entry mechanism of hepatitis C virus (HCV) and natural immunity against viruses. Previously, Wang was a faculty member in the University of Pittsburgh's department of infectious diseases and microbiology.

Chellarajan, laboratory supervisor, is the operational manager of SRI's new SRI SV preclinical laboratories and oversees the daily operation of a broad range of toxicology and pharmacology studies conducted to advance promising therapeutics from discovery  toward clinical trials. Previously, she worked at PharmaMar U.S., Millennium and Eisai.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing